Medical News

RSS

UK should continue to provide aid to India, parliamentary report says

Despite enormous economic gains over the past 25 years, Britain should continue to provide aid to India until 2015 to ensure the country meets the Millennium Development Goals (MDGs), according to a cross-party report published by the House of Commons international development committee on Tuesday, the Guardian reports.

17 Jun 2011

'Healthy food' discussed at Nutrevent 2011

How is "healthy food" defined ? Which food compounds are scientifically approved as health-enhancing ? What type of food information do consumers need or want ? Do "pharma" and "food" need more convergence to be innovative ? These were the most discussed topics during the 2011 edition of the "Nutrevent", an international innovation congress organized by the Eurasanté and the Nutrition, Health and Logevity Cluster in the French city of Lille.

17 Jun 2011

First Edition: June 17, 2011

Today's headlines include reports about how health entitlement programs are faring in the ongoing deficit-reduction negotiations.

17 Jun 2011

RHEI receives Chinese SFDA acceptance letter for MuGard

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, RHEI Pharmaceuticals has received the acceptance letter from the State Food and Drug Administration (SFDA) of China acknowledging all necessary documentation for the MuGard has been submitted and accepted.

17 Jun 2011

U.S. government's GAVI pledge took 'trade-offs' in global health portfolio

"Investments in vaccines are one of the best and most cost-effective life-saving investments for the world's children, which is why we've made tough choices and trade-offs within our current global health portfolio to make this commitment"

17 Jun 2011

Sunshine enters Adva-27a cancer research and development agreement with The Jewish General Hospital

Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.

17 Jun 2011

Sarkozy calls for G20 agriculture ministers to establish farm database

"French President Nicolas Sarkozy urged G20 agriculture ministers to agree at talks in Paris next week on a farm database that would gather and store market-sensitive information such as food stocks," Reuters reports.

17 Jun 2011

GenMark prices public offering of common stock

GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.

17 Jun 2011

U.S. food aid policies must be streamlined to prevent a food security crisis

Feed the Future programs "will indeed address hunger at its core, offering farmers the tools and opportunity they need to feed their families. ... But on the other side of town we've deepened our investments in policies that increase food insecurity.

17 Jun 2011

TRIL Centre, Age Action Ireland announce falls awareness day on June 21

The TRIL Centre and Age Action Ireland announce a falls awareness day, Tuesday 21st June 2011, the longest day of the year.

17 Jun 2011

NASDAQ halts Regeneron's common stock

Regeneron Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company's common stock.

17 Jun 2011

Encouraging results from ReShape Duo Phase 1 study for treatment of obesity

ReShape Medical, Inc. today announces results of its U.S. Phase 1 investigational clinical study. This feasibility study of thirty subjects assessed the safety and effectiveness of the ReShape Duo in conjunction with lifestyle modification in patients with a body mass index of 30-40.

17 Jun 2011

Celgene, GELA to conduct REVLIMID/rituximab combination study on newly diagnosed FL

Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma.

17 Jun 2011

CoreLab Partners' new technological solutions to be showcased at DIA 2011

CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, will showcase several new technological solutions to coincide with the upcoming DIA meeting in Chicago, Illinois to be held from June 20 - 23, 2011.

17 Jun 2011

Careful, well-designed studies needed for evaluating patients with MS: SIRF panel

Evaluating patients with multiple sclerosis who have narrowed jugular and azygos veins-and the value of widening those veins with angioplasty-warrants careful, well-designed research, noted members of a Society of Interventional Radiology Foundation's Research Consensus Panel.

17 Jun 2011

Health care in the U.S. must focus primarily on disease prevention: Surgeon General

U.S. Surgeon General Regina Benjamin said Monday that health care in the United States must shift its primary focus to disease prevention rather than the treatment of illness.

17 Jun 2011

Spanish version of MyPlate nutritional products now available at Learning ZoneXpress

A Spanish-language version of the popular MyPlate poster and handouts tablet is now available from Learning ZoneXpress.

17 Jun 2011

Women, young people more worried about EHEC bacteria outbreak in Europe

The news coverage of the deadly EHEC bacteria outbreak in Europe came as a bombshell. Ghent University (Belgium) examined 6132 reactions of Belgian newspaper readers after reading the first news reports.

17 Jun 2011

Precisely mapped allosteric binding site will facilitate design of drugs with minimal side effects

Structural biologists at Cold Spring Harbor Laboratory (CSHL) have obtained a precise molecular map of the binding site for an allosteric inhibitor in a subtype of the NMDA (N-methyl-D-aspartate) receptor, which is commonly expressed in brain cells.

17 Jun 2011

Physician payment, home health out-of-pocket costs grab headlines

The Medicare Payment Advisory Commission's latest report casts the challenges surrounding Medicare physician payment as an "opportunity" to hasten needed reform. Additionally, an analysis by Avalere Health measures the impact of a proposal for home health co-payments.

17 Jun 2011